PLASMA-LYTE R Injection (Multiple Electrolytes Injection, Type 2, USP) is a
sterile, nonpyrogenic isotonic solution in a single dose container for intravenous
administration. Each 100 mL contains 640 mg of Sodium Acetate Trihydrate, USP
(C2H3NaO2• 3H2O); 496 mg of
Sodium Chloride, USP (NaCl); 89.6 mg of Sodium Lactate (C3H5NaO3);
74.6 mg of Potassium Chloride, USP (KCl); 36.8 mg of Calcium Chloride, USP (CaCl2•
2H2O); and 30.5 mg of Magnesium Chloride, USP (MgCl2•6H2O).
It contains no antimicrobial agents. The pH is adjusted with hydrochloric acid.
The pH is 5.5 (4.0 to 8.0).
PLASMA-LYTE R Injection (Multiple Electrolytes Injection, Type 2, USP) administered
intravenously has value as a source of water, electrolytes, and calories. One
liter has an ionic concentration of 140 mEq sodium, 10 mEq potassium, 5 mEq
calcium, 3 mEq magnesium, 103 mEq chloride, 47 mEq acetate, and 8 mEq lactate.
The osmolarity is 312 mOsmol/L (calc). Normal physiologic osmolarity range is
approximately 280 to 310 mOsmol/L. Administration of substantially hypertonic
solutions may cause vein damage. The caloric content is 11 kcal/L.
The flexible container is made with non-latex plastic materials specially designed
for a wide range of parenteral drugs including those requiring delivery in containers
made of polyolefins or polypropylene. For example, the AVIVA container system
is compatible with and appropriate for use in the admixture and administration
of paclitaxel. In addition, the AVIVA container system is compatible with and
appropriate for use in the admixture and administration of all drugs deemed
compatible with existing polyvinyl chloride container systems. The solution
contact materials do not contain PVC, DEHP, or other plasticizers.
The suitability of the container materials has been established through biological
evaluations, which have shown the container passes Class VI U.S. Pharmacopeia
(USP) testing for plastic containers. These tests confirm the biological safety
of the container system.
The flexible container is a closed system, and air is prefilled in the container
to facilitate drainage. The container does not require entry of external air
The container has two ports: one is the administration outlet
port for attachment of an intravenous administration set and the other port
has a medication site for addition of supplemental medication (See Directions
for Use). The primary function of the overwrap is to protect the container
from the physical environment.
Last reviewed on RxList: 3/5/2009
This monograph has been modified to include the generic and brand name in many instances.